Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 27Myelodysplastic Syndromes 8Myeloproliferative Disorders 4Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Monocytic, Acute 3Leukemia, Myelomonocytic, Chronic 2Leukemia, Myelomonocytic, Acute 2Leukemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphoid 1Leukemia, Erythroblastic, Acute 1Disease 1Congenital Abnormalities 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 47Peripheral Blood Stem Cell Transplantation 39Cyclophosphamide 39Busulfan 37Tacrolimus 33Mycophenolic Acid 29Methotrexate 26Cytarabine 25Cyclosporine 25Whole-Body Irradiation 24Antilymphocyte Serum 23Radiotherapy 16Etoposide 16Filgrastim 15Methylprednisolone 11Melphalan 11Transplantation 9Cord Blood Stem Cell Transplantation 9Idarubicin 8sargramostim 7Sirolimus 7Mitoxantrone 7merphos 6Thiotepa 6Granulocyte Colony-Stimulating Factor 6Flow Cytometry 6Alemtuzumab 6fludarabine 5aldesleukin 5Gemtuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Congenital Abnormalities × CPX-351 × Clear all
NCT02019069 2019-01-22

CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Stanford University

Phase 2 Completed
11 enrolled 17 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡